[Skip to Content]
[Skip to Content Landing]
Comment & Response
March 2017

Targeting Staphylococcus aureus in Pediatric Surviving Sepsis Bundles

Author Affiliations
  • 1Paediatric Critical Care Research Group, Mater Research Institute, University of Queensland, Brisbane, Queensland, Australia
  • 2Paediatric Intensive Care Unit, Lady Cilento Children’s Hospital, Brisbane, Queensland, Australia
  • 3Department of Pediatrics, Inselspital, University of Bern, Bern, Switzerland
  • 4Paediatric Intensive Care Unit, The Royal Children’s Hospital, Melbourne, Victoria, Australia
  • 5Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia
  • 6Cardiothoracic Intensive Care Unit, National University Health System, Singapore
JAMA Pediatr. 2017;171(3):301. doi:10.1001/jamapediatrics.2016.4675

To the Editor McMullan et al1 reported on a large population-based cohort of children with Staphylococcus aureus bacteremia in Australia and New Zealand.1 We wish to congratulate the authors for providing insights into the burden of staphylococcal infections in children and would like to consider important implications arising from this study.

×